Jeroen Dekervel - Concepedia

Author

Jeroen Dekervel

KU Leuven ORCID

Also Known As

DEKERVEL J, Dekervel J, Dekervel Jeroen, Dekervel, Jeroen, J Dekervel, J. Dekervel, Jeroen Dekervel, Li Wen Liang

166

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

KU Leuven VIB-KU Leuven Center for Cancer Biology Ghent University Hospital Universitair Ziekenhuis Leuven Vall d'Hebron Hospital Universitari

About

Jeroen Dekervel is an author at KU Leuven specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	471
2	Health Sciences	3	3	133
3	Cell Biology	3	3	230
4	Engineering	1	1	88
5	Biomedical Engineering	1	1	19

Jeroen Dekervel

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Encorafenib, Binimetinib, and Cetuximab in <i>BRAF</i> V600E–Mutated Colorectal Cancer Scott Kopetz, Axel Grothey, Rona Yaeger, New England Journal of Medicine	2019	1.4K
Long-term exposure to sorafenib of liver cancer cells induces resistance with epithelial-to-mesenchymal transition, increased invasion and risk of rebound growth Hannah van Malenstein, Jeroen Dekervel, Chris Verslype, Cancer Letters Hepatocellular CarcinomaMedicineLiver PhysiologyLiver Cancer CellsOncogenic Agent	2012	189
Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switching Linde De Smedt, Sofie Palmans, Daan Andel, British Journal of Cancer	2016	163
DNA methylation-driven EMT is a common mechanism of resistance to various therapeutic agents in cancer Eva Galle, Bernard Thienpont, Sarah Cappuyns, Clinical Epigenetics	2020	96
[18F]AlF-NOTA-octreotide PET imaging: biodistribution, dosimetry and first comparison with [68Ga]Ga-DOTATATE in neuroendocrine tumour patients Elin Pauwels, Frederik Cleeren, Térence Tshibangu, European Journal of Nuclear Medicine and Molecular Imaging Positron Emission TomographyEngineeringOncologic ImagingMedical ImagingPet-mri	2020	88
ANCHOR CRC: Results From a Single-Arm, Phase II Study of Encorafenib Plus Binimetinib and Cetuximab in Previously Untreated <i>BRAF</i><sup>V600E</sup>-Mutant Metastatic Colorectal Cancer Eric Van Cutsem, Rona Yaeger, Takayuki Yoshino, Journal of Clinical Oncology	2023	86
PD-1- CD45RA+ effector-memory CD8 T cells and CXCL10+ macrophages are associated with response to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma Sarah Cappuyns, Gino Philips, Vincent Vandecaveye, Nature Communications	2023	65
<sup>18</sup>F-AlF-NOTA-Octreotide Outperforms<sup>68</sup>Ga-DOTATATE/NOC PET in Neuroendocrine Tumor Patients: Results from a Prospective, Multicenter Study Elin Pauwels, Frederik Cleeren, Térence Tshibangu, Journal of Nuclear Medicine	2022	63
Gemcitabine Recruits M2-Type Tumor-Associated Macrophages into the Stroma of Pancreatic Cancer Ashenafi Bulle, Jeroen Dekervel, Lise Deschuttere, Translational Oncology	2020	54
Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer Kohei Shitara, Eric Van Cutsem, Mahmut Gümüş, New England Journal of Medicine	2025	48

Page 1